BIPH NYSE Week ended 28 Aug 2026

Weekly Investor Report

Safeplus International Holdings Limited · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 15.99 USD
0.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -0.2% below the Trend Line and sits at 60.4% of its 52-week range. The latest completed week returned 0.4%, after a -1.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 40 out of 100
Latest Close 15.99 USD 28 Aug 2026
1W Return 0.4% latest completed week
4W Return -1.1% short-term follow-through
12W Return -0.3% quarterly tape
Trend Breadth 67.3% 35 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.4% Latest completed week; four-week move -1.1%. Indicator stack 37/0 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 21 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -0.2% below the Trend Line and sits at 60.4% of its 52-week range. The latest completed week returned 0.4%, after a -1.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug 21 Aug 28 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5312-week average 0.56

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.53Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.1% over four weeks, -0.3% over 12 weeks, and 1.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.4%
4W-1.1%
12W-0.3%
26W1.1%
52W1.6%
Active trend streak0 weeks
Active weeks in one year35
Trend breadth67.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.72Latest activity-pressure read.
Pressure change-550.6%Four-week change in activity pressure.
Leadership-10.04Latest relative-leadership reading.
RS change-31.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 16 Aug 2026 Financial statements through 31 May 2026 Field coverage 91% Model confidence 91%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength86/100Blend of value, momentum, and quality. Underlying universe rank 15; rank 1 is best.
Value98/100Relative valuation strength. Underlying universe rank 3; rank 1 is best.
Quality67/100Profitability and accounting quality. Underlying universe rank 34; rank 1 is best.
Momentum20/100Medium-term price momentum. Underlying universe rank 81; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
7.5x
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
5.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
22.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
26.5%
Gross profit retained from each unit of revenue.
Operating margin
24.8%
Operating profit retained from revenue.
Free-cash-flow margin
54.9%
Free cash flow generated from revenue.
Return on invested capital
7.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
25.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
7.9%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
7.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
5.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 21 relevant articles.

0 positive · 21 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-4.6%Distance below the 52-week high.
13-week volatility1.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+2.5%Week of 10 Apr.
Worst week-2.9%Week of 26 Jun.
Latest week+0.4%Week of 28 Aug.

Shape of recent returns

Strong gains0
Modest gains13
Flat weeks0
Modest losses13
Sharp losses0
Recent vol1.2%13-week weekly-return volatility.
Base vol1.4%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew1.0% / -1.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis49/100

Latest 12-week confirmation: trend 8/12, activity pressure 8/12, relative leadership 0/12.

Activity pressure 0.53; No reversal markers Factors68/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 51; Small Cap Core rank 2 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 21 relevant articles.

Safeplus International Holdings Limited (BIPH) Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
28 Aug 202615.99 USD0.4%16.03 USD15.49 USD-0.72-10.0454.1KOff
21 Aug 202615.92 USD-0.4%16.03 USD15.48 USD-0.58-10.2952.2KOff
14 Aug 202615.98 USD0.3%16.04 USD15.46 USD-0.38-11.5343.4KOn
7 Aug 202615.94 USD-1.4%16.04 USD15.45 USD-0.07-11.70158.3KOn
31 Jul 202616.16 USD-0.3%16.05 USD15.44 USD0.16-7.6695.1KOn
24 Jul 202616.21 USD-0.3%16.03 USD15.43 USD0.24-6.6551.9KOn
17 Jul 202616.25 USD1.1%16.03 USD15.42 USD0.27-7.1857.3KOn
10 Jul 202616.08 USD1.5%16.02 USD15.40 USD0.38-9.79101.1KOff
3 Jul 202615.84 USD0.1%16.02 USD15.39 USD0.26-10.18239.3KOff
26 Jun 202615.82 USD-2.9%16.03 USD15.39 USD0.38-8.5866.7KOn
19 Jun 202616.30 USD1.7%16.03 USD15.38 USD0.47-8.2977.3KOn
12 Jun 202616.02 USD-0.1%16.02 USD15.36 USD0.21-9.2940.8KOn
5 Jun 202616.03 USD-1.2%16.02 USD15.35 USD0.21-8.96111.0KOn
29 May 202616.23 USD1.5%16.02 USD15.34 USD0.06-10.4062.9KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context